Biodesix, Inc.
BDSX
$0.2867
-$0.0132-4.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.46% | 9.72% | 6.31% | 19.08% | 27.21% |
| Total Depreciation and Amortization | 1.41% | 11.03% | 20.42% | -0.42% | -8.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.82% | -10.37% | -52.40% | -3.55% | -0.37% |
| Change in Net Operating Assets | 89.33% | 109.77% | -269.39% | -214.71% | -222.71% |
| Cash from Operations | 43.82% | 66.65% | -178.04% | -2,081.96% | -99.21% |
| Capital Expenditure | 68.38% | 71.88% | 96.05% | 69.99% | 96.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.54% | -164.71% | -34.15% | -29.09% | -30.00% |
| Cash from Investing | 49.82% | 70.54% | 95.14% | 69.14% | 96.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 46.15% | 0.00% | -8.33% | 0.00% | -8.33% |
| Issuance of Common Stock | -65.60% | -99.95% | -97.72% | 67,806.17% | 113.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -97.17% | 83.64% | 94.17% | -54.06% | 96.26% |
| Cash from Financing | -87.74% | -100.83% | -98.82% | 2,301.55% | 132.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.58% | -180.09% | -544.80% | 490.69% | 16.95% |